Overall Technical outlook

Price Summary

NATCOPHARM's shares experienced a significant -3.32% decrease, indicating a unimpressive market performance.
On 2025-09-04, NATCO Pharma Limited's shares started at 884.95, peaked at 885.0, bottomed out at 850.15, and ended -3.32% down at 855.55, with 378755 shares traded.
The stock's highest value over the last 52 weeks is 1592.85, and the lowest value is 746.5.
According to 11 analysts, the future price is anticipated to vary between 710.0 and 1480.0, with an average expected price of around 997.9091.

Technicals

Support and Resistance: The current price sits at 855.55, supported at 809.6 and capped by resistance at 902.85. These levels define a range for NATCOPHARM where the price might stabilize, with 809.6 as a floor and 902.85 as a ceiling.
NATCOPHARM supportResistance f1650d
Support/Resistance for NATCOPHARM


Aroon: The current reading of the AROON indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
NATCOPHARM aroon f1650d
Aroon chart for NATCO Pharma Limited


Bol. Bands: The BOLL BANDS is in a neutral stance for NATCOPHARM, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
NATCOPHARM bbands f1650d
Bolinger Bands chart for NATCO Pharma Limited


Parabolic SAR: The PSAR maintains its bearish stance, establishing a resistance level that could cap any attempts at upward movement. This persistent bearish outlook suggests that the market may continue to face downward pressure, with resistance preventing significant gains.
NATCOPHARM psar f1650d
Parabolic Stop and Reverse chart for NATCO Pharma Limited


Stochastic: The current state of the STOCHASTIC is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
NATCOPHARM stoch f1650d
Stochastic chart for NATCO Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral stance, with no definitive indication of an upward or downward trend for NATCOPHARM. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
NATCOPHARM trippleSMA f1650d
Tripple SMA chart for NATCO Pharma Limited


Before focusing on a company's technical data, such as stock price movements, it's essential to analyze its fundamentals. These include factors like profitability, cash flow, and debt management. Additionally, considering the broader industry landscape—including market trends, competition, and regulatory changes—offers deeper insights. This comprehensive approach allows for a more meaningful interpretation of the company's technical indicators, providing a clearer picture of its financial health and future prospects.